With the identification of candidate podocyte antigen targets such as PLA2R and THSD7A and their respective PLA2R and anti-THSD7A autoantibodies, the autoimmune basis of MGN has effectively been established. The gene discussed is PLA2R1; the disease is idiopathic membranous glomerulonephritis.